Indoor environment (pediatrics): Difference between revisions
Feedback

From WikiLectures

No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__TOC__
__TOC__
'''Vnitřním prostředím''' organismu jsou '''tělesné tekutiny'''. V tělesných tekutinách je rozpouštědlem [[voda]] a v ní jsou rozpuštěny látky v ionizované nebo neionizované formě. Ionizovanou formu představují '''elektrolyty''', tj. látky, které po rozpuštění ve vodě tvoří kladné nebo záporně nabité částice: kationty a anionty. V tělesných tekutinách probíhají veškeré metabolické pochody. Udržení optimálního množství a složení tělesných tekutin je nezbytnou podmínkou pro činnost orgánů, pro základní životní funkce. Stálost vnitřního prostředí nazýváme '''[[homeostáza|homeostázou]]'''.
The body fluids are the internal environment of the organism. In body fluids, the solvent is [[water]] and substances are dissolved in it in ionized or non-ionized form. The ionized form is represented by ``electrolytes'', i.e. substances that, when dissolved in water, form positively or negatively charged particles: cations and anions. All metabolic processes take place in body fluids. Maintaining the optimal amount and composition of body fluids is a necessary condition for the functioning of organs, for basic vital functions. We call the stability of the internal environment '''[[homeostasis|homeostasis]]'''.


=== [[Celková tělesná voda]] ===
=== [[Total Body Water]] ===
Zatímco většina životně důležitých pochodů probíhá v [[intracelulární tekutina|ICT]], [[extracelulární tekutina|ECT]] primárně slouží jako medium pro dopravu látek, které jsou pro tyto pochody nezbytné. V průběhu vývoje jedince se mění nejen celkový objem tělesných tekutin, ale i jednotlivé kompartmenty, zatímco relativně konstantní je koncentrace solutů.
While most vital processes take place in [[intracellular fluid|ICT]], [[extracellular fluid|ECT]] primarily serves as a medium for the transport of substances necessary for these processes. During the development of an individual, not only the total volume of body fluids changes, but also individual compartments, while the concentration of solutes is relatively constant.


;Rozdělení celkové tělesné vody (CTV):
;Distribution of total body water (CTV):
* intracelulární tekutina (ICT),
* intracellular fluid (ICT),
* extracelulární tekutina (ECT),
* extracellular fluid (ECT),
::* intravaskulární tekutina (IVT = [[plazma]]): je ohraničena [[endotel]]ovými buňkami a vytváří prostředí pro krevní elementy,
::* intravascular fluid (IVT = [[plasma]]): is bounded by [[endothelial]] cells and creates an environment for blood elements,
::* intersticiální tekutina (IST) a [[lymfa]]: tvoří největší část ECT, je vložena mezi ICT a jiné části ECT, probíhá v ní výměna vody a solutů mezi ICT a ECT,
::* interstitial fluid (IST) and [[lymph]]: make up the largest part of ECT, it is inserted between ICT and other parts of ECT, exchange of water and solutes between ICT and ECT takes place in it,
::* transcelulární tekutina = sekrety GIT, [[moč]], [[likvor]], nitrooční tekutina, [[pot]] v [[potní žlázy|potních žlazách]] aj.,
::* transcellular fluid = GIT secretions, [[urine]], [[CSF]], intraocular fluid, [[sweat]] in [[sweat glands|sweat glands]] etc.,
::* tekutina vazivové tkáně, chrupavek a kostí: je vlastně součástí intersticiální tekutiny, ale některé soluty jako [[glukóza]] nebo větší molekuly nepřecházejí volně do tohoto prostoru.
::* the fluid of fibrous tissue, cartilage and bones: it is actually part of the interstitial fluid, but some solutes such as [[glucose]] or larger molecules do not pass freely into this space.


Platí, že čím je dítě mladší, tím větší podíl mají tekutiny na tělesné hmotnosti, a tím větší část tělesných tekutin je extracelulárně, především jako IST. Čím je dítě mladší, tím má totiž oproti dospělému proporcionálně menší objem svalů a orgánů (obsahují více ICT). ECT je také vyměňována u kojence během 24 hodin 4x intenzivněji, s ohledem na jednotku tělesné hmotnosti nebo tělesného povrchu, než u dospělého organismu. Kritické stavy u dětí jsou vždy komplikovány značnou labilitou tělesných tekutin (rychlý vznik [[Dehydratace (pediatrie)|dehydratace]]) a relativně vysokou fyziologickou potřebou.
It is true that the younger the child, the greater the proportion of fluids in body weight, and the greater part of body fluids is extracellular, mainly as IST. The younger the child, the smaller the volume of muscles and organs (they contain more ICT) compared to an adult. ECT is also exchanged in an infant during 24 hours 4 times more intensively, with respect to a unit of body weight or body surface, than in an adult organism. Critical conditions in children are always complicated by significant lability of body fluids (rapid onset of [[Dehydration (pediatrics)|dehydration]]) and relatively high physiological need.


;Normální objem [[krev|krve]] v množství na 1 kg tělesné hmotnosti:
;Normal volume of [[blood|blood]] in quantity per 1 kg of body weight:
* [[novorozenec]]: 90 ml,
* [[newborn]]: 90 ml,
* 1 6 let: 80 ml,
* 1 to 6 years: 80 ml,
* 6 8 let: 75 ml,
* 6 to 8 years: 75 ml,
* dospělý: 60 70 ml.
* adult: 60 to 70 ml.


<center>
<center>
{| class="wikitable"
{| class="wikitable"
  |+ '''''Zastoupení hlavních solutů'''''
  |+ '''''Representation of major solutes'''''
  |-
  |-
  ! style="background:#ffdead;" |
  ! style="background:#ffdead;" |
  | style="background:#ffdead;" | '''ICT''' || style="background:#ffdead;" | '''ECT'''  
  | style="background:#ffdead;" | '''ICT''' || style="background:#ffdead;" | '''ECT''''
  |-
  |-
  ! style="background:#ffdead;" | [[kationty]]
  ! style="background:#ffdead;" | [[cations]]
  |  
  |
* [[kalium]]  
* [[potassium]]
* [[magnesium]]  
* [[magnesium]]
||
||
* [[natrium]]  
* [[sodium]]
* kalium
* potassium
  |-
  |-
  ! style="background:#ffdead;" | [[anionty]]
  ! style="background:#ffdead;" | [[anions]]
  |  
  |
* [[fosfáty]]  
* [[phosphates]]
* [[bílkoviny]]  
* [[proteins]]
||  
||
* [[chloridy]]  
* [[chlorides]]
* [[bikarbonát]]
* [[bicarbonate]]
|}
|}
</center>
</center>


=== [[Osmolalita]] ===
=== [[Osmolality]] ===
'''Osmolalita tělesných tekutin''' je dána množstvím částic v nich rozpuštěných, které jsou schopny působit na vodu kolem sebe nebo na druhé straně pro vodu propustné membrány. Nezáleží na velikosti částic. Množství částic (solutů) v jednotce hmotnosti rozpouštědla, vyjádřeno na kg nebo na litry vody, se nazývá '''osmolalita''' a udává se v jednotkách mmol/kg, resp. mOsm/kg. Rozdíl množství osmoticky aktivních (na vodu působících) částic na obou stranách pro vodu propustných membrán je '''[[osmotický tlak]]''', osmotický koncentrační gradient. Jsme schopni měřit a léčebně ovlivňovat osmolalitu IVT.
The ''osmolality'' of body fluids is determined by the amount of particles dissolved in them, which are able to act on the water around them or on the other side of the water-permeable membrane. Particle size does not matter. The amount of particles (solutes) in a unit of solvent mass, expressed per kg or per liter of water, is called "osmolality" and is given in units of mmol/kg, respectively. mOsm/kg. The difference in the amount of osmotically active (water-acting) particles on both sides of the water-permeable membranes is '''[[osmotic pressure]]''', the osmotic concentration gradient. We are able to measure and therapeutically influence the osmolality of IVT.
Protože hlavní osmoticky aktivní složkou ECT a krevní plazmy je natrium, výrazné odchylky v hospodaření s vodou se typicky projevují ve formě [[hyponatrémie]] (Na < 130 mmol/l), resp. [[hypernatrémie]] (Na > 150 mmol/l). Organismus si musí zabezpečit nejen izoosmolalitu, ale i izoionii a to nejen v ECT, ale i v dalších kompartmentech.
Since the main osmotically active component of ECT and blood plasma is sodium, significant deviations in water management are typically manifested in the form of [[hyponatremia]] (Na < 130 mmol/l), or [[hypernatremia]] (Na > 150 mmol/l). The organism must ensure not only iso-osmolality, but also isoion, not only in the ECT, but also in other compartments.


==== [[Osmolalita séra|Efektivní osmolalita]] (tonicita) ====
==== [[Serum osmolality|Effective osmolality]] (tonicity) ====
[[Soubor:Osmotic pressure on blood cells diagram.svg|thumb|right|Vliv různého osmotického tlaku na erytrocyty]]
[[File:Osmotic pressure on blood cells diagram.svg|thumb|right|Effect of different osmotic pressure on erythrocytes]]
Z klinického pohledu je důležitější tzv. '''efektivní osmolalita''' (tonicita), která závisí od počtu "nepenetrujících" částic v ECT (zejm. natrium a anionty) a ICT (zejm. kalium a fosfát se svými anionty). Právě tyto soluty tvoří osmotický koncentrační gradient, který vyvíjí osmotickou aktivitu a tím ovlivňuje distribuci vody mezi ICT a ECT, tj. udržuje vodu na své straně buněčné membrány.
From a clinical point of view, the so-called ''effective osmolality'' (tonicity) is more important, which depends on the number of "non-penetrating" particles in ECT (mainly sodium and anions) and ICT (mainly potassium and phosphate with their anions). It is these solutes that form an osmotic concentration gradient, which develops osmotic activity and thereby affects the distribution of water between ICT and ECT, i.e. it keeps water on its side of the cell membrane.


Hodnoty tonicity a osmolality jsou většinou identické, ale mohou nastat případy, kdy tomu tak není: tzv. "penetrující" soluty, např. [[močovina]] (urea) lehce přechází přes buněčné membrány, ale změna její koncentrace nemá (nebo má jen dočasně) vliv na osmotický pohyb vody mezi jednotlivými tělesnými kompartmenty. Jinými slovy, přestože [[azotémie]] zvyšuje celkovou osmolalitu plasmy, neovlivňuje její tonicitu. Nekriticky přijímané hodnoty celkové osmolality u těchto pacientů mohou proto vést k nesprávnému terapeutickému závěru.
The values ​​of tonicity and osmolality are mostly identical, but there may be cases when this is not the case: so-called "penetrating" solutes, e.g. temporarily) influence on the osmotic movement of water between individual body compartments. In other words, although [[azotemia]] increases total plasma osmolality, it does not affect plasma tonicity. Uncritically accepted values ​​of total osmolality in these patients can therefore lead to an incorrect therapeutic conclusion.
Some substances, on the other hand, increase the effective osmolality and are not included in the calculation according to the formula (see formula 2). It can be substances that we use therapeutically (e.g. [[mannitol]]) or substances that are found in [[intoxication|intoxication]] ([[alcohol]], [[methanol]]). If other exogenous osmotically active substances (e.g. mannitol) are not present in the plasma, osmolality or tonicity can be calculated according to simple formulas:


Některé látky naopak efektivní osmolalitu zvyšují a přitom je ve výpočtu podle vzorce (viz vzorec 2) nepostihneme. Může jít o látky, které využíváme terapeuticky (např. [[mannitol]]) nebo o látky, které nacházíme u [[intoxikace|intoxikací]] ([[alkohol]], [[methanol]]). Pokud nejsou v plasmě přítomny jiné, exogenní osmoticky aktivní látky (např. mannitol), dá se osmolalita nebo tonicita vypočítat dle jednoduchých vzorců:
{| style="background:#DDFBDD"
 
{| style="background:#DDFBDD"  
|
|
* ''Vzorec 1:'' '''S-osmolalita = 2x Na + glykemie + urea '''  
* ''Formula 1:'' '''S-osmolality = 2x Na + glycemia + urea '''
* ''Vzorec 2:'' '''Efektivní osmolalita, S-tonicita = 2x (Na + glykémie)'''; 2x Na + 10  
* ''Formula 2:'' '''Effective osmolality, S-tonicity = 2x (Na + glycemia)'''; 2x Na + 10
|}<ref>{{Citace|typ = kniha|příjmení1 = Šašinka |jméno1 = M|kolektiv = an|titul = Pediatria, zv. I a II|vydání = 1   |místo = Košice|vydavatel = Satus   |rok = 1998 |rozsah =|edice =  |svazek =|isbn = 80-967963-0-5   |strany =}}</ref>
|}<ref>{{Cite|type = book|surname1 = Šašinka |name1 = M|others = yes|title = Pediatrics |volume = I and II|edition = 1 location = Košice|publisher = Satus |year = 1998 |isbn = 80-967963-0-5}}</ref>


S-tonicita kalkuluje jen s "nepenetrujícími" soluty a představuje z klinického hlediska tzv. efektivní osmolalitu. Kalkuluje jen s ionty a glukózou.
S-tonicity calculates only with "non-penetrating" solutes and represents, from a clinical point of view, the so-called effective osmolality. It only calculates with ions and glucose.


{| style="background:#DDFBDD"  
{| style="background:#DDFBDD"
|Osmolalitu jednotlivých kompartmentů si organismus udržuje v úzkém rozmezí a hodnoty 280 295 mmol/kg považujeme za fyziologické rozmezí S-osmolality.
|The organism maintains the osmolality of individual compartments within a narrow range, and values ​​of 280 to 295 mmol/kg are considered to be the physiological range of S-osmolality.
|}
|}


'''[[Osmolalita séra|Hypoosmolalita]] plazmy''' S-osmo < 275 mmol/kg svědčí o relativním nadbytku tělesné vody v poměru k tělesným solutům.  
'''[[Serum osmolality|Hypoosmolality]] of plasma''' S-osmo < 275 mmol/kg indicates a relative excess of body water in relation to body solutes.
'''[[Hyperosmolalita]] plazmy''' S-osmo > 295 mmol/kg svědčí o relativním deficitu tělesné vody v poměru k tělesným solutům.
'''[[Hyperosmolality]] of plasma''' S-osmo > 295 mmol/kg indicates a relative deficit of body water in relation to body solutes.
{{Podrobnosti|Osmolalita séra}}
{{Details|Serum Osmolality}}
==== Idiogenní osmoly ====
Když se u pacienta náhle změní osmolalita ECT, nastane přesun vody, který okamžitě vyrovná rozdíly v osmotické koncentraci na obou stranách buněčné membrány. Tato rychlá kompenzace sice zmírní velikost osmotické zátěže v ECT, ale jen za cenu současného odvodnění a svraštění buněk (při hyperosmolalitě plazmy), resp. jejich otoku (při hypoosmolalitě plazmy). Buňky [[CNS]] mají na odvrácení osmotického poškození i další kompenzační mechanismus, který se však v plné parádě projeví až po 6 až 12 hodinách trvání hyper/hypoosmolality plazmy. Při dlouhodobém zvýšení osmolality vznikají postupnou degradací buněčných makromolekul osmoticky aktivní částice, tzv. '''idiogenní osmoly'''. Jejich vznik je provázen následným vzestupem intracelulární osmolality a úpravou objemu buněk CNS. Díky této kompenzaci dokáží pacienti s chronickou hypernatrémií nebo [[diabetická ketoacidóza|diabetickou ketoacidózou]] tolerovat extremně vysoké hodnoty osmolality plazmy. Naopak při prolongovaném snížení osmolality, dokáží buňky CNS snížit počet intracelulárních solutů a tím získat svůj původní objem i přes přetrvávající hypoosmolalitu plazmy. Existenci této sekundární "opožděné" kompenzace je třeba vzít v úvahu při korekci déletrvajících [[poruchy vodní homeostázy|poruch vodní homeostázy]].


==== Osmotické okno ====
==== Idiogenic osmoles ====
V některých klinických situacích je užitečné určit '''osmolární/osmotické okno''' (osmolal/osmotic gap, OG), které vyjadřuje rozdíl mezi přímo měřenou osmolalitou osmometrem a vypočítanou osmolalitou podle vzorce 1.
When the patient's ECT osmolality suddenly changes, a water shift occurs that immediately balances the differences in osmotic concentration on either side of the cell membrane. Although this rapid compensation reduces the magnitude of the osmotic load in ECT, it is only at the cost of simultaneous drainage and shriveling of the cells (at hyperosmolality of the plasma), or their swelling (with plasma hypoosmolality). The [[CNS]] cells also have another compensatory mechanism to prevent osmotic damage, but it is fully manifested only after 6 to 12 hours of plasma hyper/hypoosmolality. With a long-term increase in osmolality, osmotically active particles, so-called ``idiogenic osmoles'', are formed by the gradual degradation of cellular macromolecules. Their formation is accompanied by a subsequent rise in intracellular osmolality and an adjustment in the volume of CNS cells. Thanks to this compensation, patients with chronic hypernatremia or [[diabetic ketoacidosis|diabetic ketoacidosis]] can tolerate extremely high plasma osmolality values. On the contrary, with a prolonged decrease in osmolality, CNS cells can reduce the number of intracellular solutes and thereby regain their original volume despite the persistent hypoosmolality of the plasma. The existence of this secondary "delayed" compensation must be taken into account in the correction of long-lasting [[disorders of water homeostasis|disorders of water homeostasis]].


{| style="background:#DDFBDD"  
==== Osmotic window ====
|Fyziologická hodnota osmotic gap je  4 – 12 mmol/kg.
In some clinical situations, it is useful to determine the ''osmolar/osmotic window'' (osmolal/osmotic gap, OG), which expresses the difference between the osmolality directly measured by the osmometer and the osmolality calculated according to formula 1.
 
{| style="background:#DDFBDD"
|The physiological value of the osmotic gap is 4 – 12 mmol/kg.
|}
|}


OG vzniká tím, že osmometrem změříme i soluty, které nejsou započítány ve vzorci. Pokud plasma obsahuje významné množství těchto nezapočítaných osmoticky aktivních látek (např. methanol, ethanol, mannitol, idiogenní osmoly při diabetické ketoacidóze) vznikne velký rozdíl mezi měřenou a počítanou hodnotou osmolality. OG využijeme zejm. při diagnostice otrav. Při hodnotě osmotického okna > 20 mOsm/l při současné MAC nejasné etiologie nutno vyloučit intoxikaci osmoticky aktivními látkami jako jsou ethanol, methanol, [[ethylenglykol]].
OG is created by measuring solutes that are not included in the formula with an osmometer. If the plasma contains a significant amount of these unaccounted for osmotically active substances (e.g. methanol, ethanol, mannitol, idiogenic osmoles in diabetic ketoacidosis), there will be a large difference between the measured and calculated osmolality values. We will use OG especially in the diagnosis of poisoning. In case of an osmotic window value > 20 mOsm/l with simultaneous MAC of unclear etiology, intoxication with osmotically active substances such as ethanol, methanol, [[ethylene glycol]] must be ruled out.


=== Regulace objemu tělesných tekutin ===
=== Regulation of body fluid volume ===
Stálost objemu tělesných tekutin je sledována velmi úzkostlivě. Již odchylky v rozmezí plus mínus 1 % od rovnovážného stavu (steady state) jsou registrovány. Z různých kompartmentů tělesných tekutin má klíčovou úlohu při regulaci CTV objem plazmy, který je monitorovaný speciálními '''objemovými receptory (volumoreceptory)'''. Jsou to jednak high pressure baroreceptory v arteriálním řečišti (arcus [[aorta]]e a sinus caroticus) a low pressure volumoreceptory ve velkých žilách, v [[srdce|srdci]] a hrudníku. Signály z těchto receptorů se přenáší do regulačních center v CNS prostřednictvím n. glossopharyngicus, [[nervus vagus|n. vagus]] a [[sympaticus|sympatiku]]. Zde v [[medulla oblongata]], [[pons Varoli]] a [[hypothalamus|hypothalamu]] jsou podněty zpracovány a podle objemu a [[osmolalita|osmolality]] tělesných tekutin jsou aktivovány efektorové mechanismy, jako je [[ADH]], systémy [[RAA systém|renin-angiotenzin-aldosteron]], kalikrein-[[bradykinin]], [[ledviny|renální]] [[prostaglandiny]], [[natriuretické peptidy]], [[autonomní nervový systém]] a další. Všechny tyto mechanismy udržují rovnováhu objemu (a osmolality) tělesných tekutin změnami činnosti srdce, průsvitu cév, vylučováním sodíku a vody. Exkrece se děje především ledvinami, [[kůže|kůží]], vydechovanými plyny a trávicím traktem, ovlivňuje ji zvýšení či snížení pocitu žízně a příjmu tekutin.
The constancy of the volume of body fluids is monitored very carefully. Deviations in the range of plus or minus 1% from the steady state are already registered. Among the various compartments of body fluids, the plasma volume, which is monitored by special ''volume receptors (voloreceptors)'', plays a key role in the regulation of CTV. They are on the one hand high pressure baroreceptors in the arterial bed (arcus [[aorta]]e and sinus caroticus) and low pressure volumoreceptors in the large veins, in the [[heart|heart]] and chest. Signals from these receptors are transmitted to regulatory centers in the CNS via the glossopharyngeal nerve, [[nervus vagus|n. vagus]] and [[sympaticus|sympathetic]]. Here in the [[medulla oblongata]], [[pons Varoli]] and [[hypothalamus|hypothalamus]], stimuli are processed and effector mechanisms such as [[ADH] are activated according to the volume and [[osmolality|osmolality]] of body fluids ], systems [[RAA system|renin-angiotensin-aldosterone]], kallikrein-[[bradykinin]], [[kidney|renal]] [[prostaglandins]], [[natriuretic peptides]], [[autonomic nervous system] ] and more. All these mechanisms maintain the balance of body fluid volume (and osmolality) by changes in cardiac activity, vascular lumen, sodium and water excretion. Excretion occurs primarily through the kidneys, [[skin|skin]], exhaled gases and the digestive tract, and is affected by an increase or decrease in thirst and fluid intake.


Primárním mechanismem regulace objemu ECT a ICT je exkrece sodíku ledvinami a zvýšení nebo snížení příjmu tekutin mechanismem žízně. Zajímavé je, že změny objemu v těle se detekují nezávisle od koncentrace natria: přes volumoreceptory, ale regulace objemu je zprostředkována zejména regulací exkrece natria ledvinami.
The primary mechanism of volume regulation of ECT and ICT is renal sodium excretion and increased or decreased fluid intake by the thirst mechanism. Interestingly, volume changes in the body are detected independently of the sodium concentration: through volumoreceptors, but volume regulation is mainly mediated by the regulation of sodium excretion by the kidneys.


=== Regulace osmolality tělesných tekutin ===
=== Regulation of osmolality of body fluids ===
'''Stabilní osmolalita tělesných tekutin''' je udržována schopností [[ledviny|ledvin]] měnit [[osmolalita|osmolalitu]] [[moč]]e a ovlivněním příjmu vody mechanismem žízně. Ledviny jsou schopny měnit osmolalitu moči v širokém rozmezí 50 1400 mmol/kg a tak podle potřeby měnit množství vylučovaných solutů a [[voda|vody]].
'''Stable osmolality of body fluids''' is maintained by the ability of the [[kidney|kidney]] to change the [[osmolality|osmolality]] of [[urine]] and by influencing water intake through the thirst mechanism. The kidneys are able to change the osmolality of urine in a wide range of 50 to 1400 mmol/kg and thus change the amount of excreted solutes and [[water|water]] as needed.


'''Změny osmolality''' monitorují '''osmoreceptory''' osmoregulačního centra v [[hypothalamus|hypothalamu]], které již při změně osmolality o 1 % spouští regulační mechanismy s cílem upravit osmolalitu. Při zvýšení osmolality [[sérum|séra]] jde především o zvýšení příjmu vody mechanismem žízně a o sekreci [[ADH]] s tvorbou koncentrované moči. Opačné pochody startují při snížení osmolality. Stimulem pro sekreci ADH je zvyšující se osmolalita sera i některé neosmolární faktory jako hypovolémie, [[bolest]], [[hypoxie]], [[Renin-angiotenzin-aldosteronový systém|RAAS]]. Sekreci ADH inhibuje S-osmolalita < 280 mmol/kg, hypervolémie, distenze levé síně. Osmolalita při které pociťujeme žízeň ([[mechanismus žízně]]) je 290mmol/kg.
'''Changes in osmolality'' are monitored by the '''osmoreceptors''' of the osmoregulation center in the [[hypothalamus|hypothalamus]], which already trigger regulatory mechanisms to adjust osmolality when the osmolality changes by 1%. An increase in [[serum|serum]] osmolality is mainly due to an increase in water intake through the thirst mechanism and the secretion of [[ADH]] with the formation of concentrated urine. The opposite processes start when osmolality is reduced. The stimulus for ADH secretion is increasing serum osmolality as well as some non-osmolar factors such as hypovolemia, [[pain]], [[hypoxia]], [[Renin-angiotensin-aldosterone system|RAAS]]. ADH secretion is inhibited by S-osmolality < 280 mmol/kg, hypervolemia, left atrial distension. The osmolality at which we feel thirsty ([[thirst mechanism]]) is 290 mmol/kg.


=== Elektroneutralita tělesných tekutin ===
=== Electroneutrality of body fluids ===
'''Elektroneutralita tělesných tekutin''' spolu s osmolalitou jsou určujícími faktory složení tělesných tekutin. V tělesných tekutinách platí tzv. '''Gibbson-Donnanova rovnováha'''. Elektroneutralitu extracelulární tekutiny lze vyjádřit rovnicí (''Vzorec 3''):
''Electroneutrality of body fluids'' together with osmolality are determining factors of body fluid composition. In body fluids, the so-called ''Gibbson-Donnan equilibrium'' applies. The electroneutrality of the extracellular fluid can be expressed by the equation (''Formula 3''):


{| style="background:#DDFBDD"  
{| style="background:#DDFBDD"
|Na + K + Ca + Mg + H = OH + Cl + HCO3 + CO2 + albumin + fosfáty
|Na + K + Ca + Mg + H = OH + Cl + HCO3 + CO2 + albumin + phosphates
|}  
|}


Ale právě pro zachování elektroneutrality není koncentrace iontů ve všech kompartmentech ECT totožná. IST má více [[chloridy|chloridů]] než [[plazma]], protože zde je vysoký obsah bílkovin. V rovnici (''Vzorec 3'') to vyjadřuje na straně aniontů albumin. Negativní náboj bílkovin přispívá i k udržení sodíku v IVT a IST. '''Starlingův zákon''' říká, že na arteriální straně kapiláry má převahu intrakapilární hydraulický tlak, zatímco na venosním konci hrají hlavní roli pro návrat tekutiny z IST do IVT plazmatické [[bílkoviny]] svým [[onkotický tlak|onkotickým tlakem]]. Patologické vlivy, jako [[hypoalbuminémie]] či [[arteriální hypertenze]], mohou transport vody ovlivňovat.  
But precisely to maintain electroneutrality, the concentration of ions in all ECT compartments is not the same. IST has more [[chlorides|chlorides]] than [[plasma]] because of the high protein content. In the equation (''Formula 3'') this is expressed on the anion side by albumin. The negative charge of proteins also contributes to sodium retention in IVT and IST. '''Starling's Law''' states that intracapillary hydraulic pressure predominates on the arterial side of the capillary, while at the venous end plasma [[proteins]] play a major role in the return of fluid from the IST to the IVT with their [[oncotic pressure|oncotic pressure] ]. Pathological influences, such as [[hypoalbuminemia]] or [[arterial hypertension]], can affect water transport.


Pokud jde o zachování elektroneutrality mezi ECT a ICT, hrají významnou roli aktivní '''enzymatické mechanismy''', jako třeba ''Na-K-ATPáza''. Elektrické síly nefiltrovatelných intracelulárních aniontů přitahují kationty z ECT, především [[sodík]]. Ten je aktivně transportován z buňky zpět. K udržení elektroneutrality i osmolality je vyměňován za draslík aktivně transportovaný intracelulárně, kde je hlavním kationtem. Udržování koncentračních gradientů Na a K je energeticky velmi náročný proces a faktory, které ho ovlivňují mohou způsobit závažné poruchy ve složení ECT a ICT.
When it comes to maintaining the electroneutrality between ECT and ICT, active '''enzymatic mechanisms'''' such as ''Na-K-ATPase'' play a significant role. The electrical forces of non-filterable intracellular anions attract cations from the ECT, primarily [[sodium]]. It is actively transported back from the cell. To maintain electroneutrality and osmolality, it is exchanged for potassium that is actively transported intracellularly, where it is the main cation. The maintenance of Na and K concentration gradients is a very energy-demanding process, and factors affecting it can cause serious disturbances in the composition of ECT and ICT.


{| style="background:#DDFBDD"  
{| style="background:#DDFBDD"
|Příliš rychlá úprava hyperosmolality může vést ke vzniku [[edém]]u buněk CNS => [[intrakraniální hypertenze|intrakraniální hypertenzi]], rychlá úprava hypoosmolality přináší riziko "svraštění" buněk CNS => [[syndrom pontinní myelinolýzy]].
|Too rapid adjustment of hyperosmolality can lead to [[edema]] in CNS cells => [[intracranial hypertension|intracranial hypertension]], rapid adjustment of hypoosmolality brings the risk of "shrinking" of CNS cells => [[pontine myelinolysis syndrome]].
|}  
|}
 
=== Elektrolytová homeostáza u novorozenců ===
'''Vodní a elektrolytová homeostáza [[novorozenec|novorozenců]]''' narozených v termínu nebo nedonošenců se v mnoha směrech liší od jiných věkových kategorií dětí. Vodní bilanci novorozenců charakterizují velmi rychlé změny distribuce vody z ECT, ale i ICT a převážně se tak děje [[ledviny|ledvinami]]. Ztráty vody jsou provázeny ztrátami [[sodík]]u, [[nedonošenec|nedonošenci]] přitom ztrácejí větší množství sodíku než novorozenci narození v termínu. Lze to dobře dokumentovat při vyšetřování exkrekční frakce pro sodík (FE Na), která je obvykle > 5 %. K jejímu snížení obvykle dochází v průběhu 1. měsíce života, u nedonošenců je tento interval delší. Je to důsledek tubulární nezralosti ledvin. Novorozenci i nedonošenci jsou tak krátce po porodu v negativní sodíkové bilanci, která někdy vyžaduje i suplementaci. Dosažení pozitivní sodíkové bilance je důležité z hlediska dalšího správného růstu a vývoje. Není vzácné, že u [[kojenec|kojenců]], kteří se narodili předčasně, dochází ve věku 4 až 6 týdnů k manifestaci pozdní [[hyponatrémie]]. Ta není důsledkem nadměrných ztrát, ale je výsledkem zvýšené inkorporace sodíku do tkání při akceleraci růstu.


;Nejčastější příčiny hyponatremie u novorozenců/nedonošenců :
=== Electrolyte homeostasis in neonates ===
* excesivní parenterální dodávka roztoků [[glukóza|glukózy]],
'''Water and electrolyte homeostasis of [[neonate|neonates]]''' born at term or preterm differs in many ways from other age categories of children. The water balance of newborns is characterized by very rapid changes in the distribution of water from ECT, but also from ICT, and this mainly happens through the [[kidneys|kidneys]]. Water losses are accompanied by [[sodium]] losses, [[premature|premature infants]] lose more sodium than term newborns. This can be well documented by examining the excretion fraction for sodium (FE Na), which is usually >5%. Its reduction usually occurs during the 1st month of life, in premature babies this interval is longer. It is a result of renal tubular immaturity. Newborns and premature babies are therefore in a negative sodium balance shortly after birth, which sometimes requires supplementation. Achieving a positive sodium balance is important for further proper growth and development. It is not uncommon for premature [[infant|infants]] to manifest late [[hyponatremia]] by 4 to 6 weeks of age. This is not a consequence of excessive losses, but is the result of increased incorporation of sodium into tissues during growth acceleration.
* [[průjem]],
* těžká [[sepse]] (dysfunkce sodíkové pumpy),
* [[srdeční selhání]],
* farmaka ([[diuretika]], [[Neopioidní analgetika|indometacin]]).


;Nejčastější příčiny hypernatremie u novorozenců/nedonošenců :
The most common causes of hyponatremia in newborns/premature infants:
* [[fototerapie]]
* excessive parenteral supply of [[glucose|glucose]] solutions,
* vrozené defekty kůže
* [[diarrhea]],
* defekty uzávěru přední stěny břišní (zvýšené [[Perspiratio insensibilis|insenzibilní ztráty]])
* severe [[sepsis]] (sodium pump dysfunction),
* [[resuscitace]] s excesivní dodávkou [[bikarbonát]]u
* [[Heart Failure]],
* pharmaceuticals ([[diuretics]], [[Non-opioid analgesics|indomethacin]]).


=== Doporučení k problematice vnitřního prostředí ===
The most common causes of hypernatremia in newborns/premature infants:
Při sledování změn homeostázy a jejich případné nápravě musíme mít na mysli některé '''obecné postoje'''.
* [[phototherapy]]
* Rozhodující je '''klinický stav nemocného'''. Cílem není "normální" [[osmolalita]] séra, ale dobrý stav pacienta: správná plynová výměna, adekvátní efektivně cirkulující [[krev]]ní objem ECKO, dobrý stav [[vědomí]] a [[diuréza|diurézy]], dobré periferní prokrvení. Je-li diskrepance mezi klinickým nálezem a výsledky laboratorních vyšetření, pak vyšetření opakujeme a výsledky hodnotíme pomocí co největší množiny informací. Samotný údaj, že koncentrace draslíku v séru je 4,8 mmol/l, nic neznamená. Pro interpretaci tohoto výsledku potřebujeme přinejmenším vědět jaká je hodnota [[pH]], koncentrace [[Natrium|Na]] a [[Chloridy|Cl]] v [[sérum|séru]], stav hydratace nemocného, funkce [[ledviny|ledvin]], [[EKG]] křivka a svalová síla.
* congenital skin defects
* '''Jednotlivý parametr''' má značně omezený význam. Důležitý je trend změn homeostázy, sledování změn mnoha parametrů v čase. Slouží k tomu bilance, sledování odpadů Na, [[Kalium|K]], Cl, [[močovina|močoviny]] a vody atd. Stálost vnitřního prostředí je dynamický děj.
* defects of the closure of the anterior abdominal wall (increased [[Perspiratio insensibilis|insensible losses]])
* Změny homeostázy nastávají většinou '''pomalu''', během 48 hodin i déle. Organismus změny registruje, kompenzuje a adaptuje se na ně. Snaha napravit odchylku od referenčního rozmezí homeostázy rychle, během minut, je pro nemocného většinou nebezpečná. Napravujeme jen změny homeostázy, které ohrožují vitální funkce nemocného.
* [[resuscitation]] with excessive supply of [[bicarbonate]]u
* ''' Rychlou''' nápravu během vteřin až minut vyžaduje :
::* [[hypoxie]],
::* [[hypotenze]],
::* [[hypoglykémie]],
::* [[křeče]].


Všechny ostatní změny homeostázy nám poskytují možnost nemocného komplexně vyšetřit a sledovat klinicky i pomocí laboratorních vyšetření. Bude u nich nutná uvážlivá náprava případných poruch homeostázy tak, abychom nenarušili adaptační a kompenzační změny organismu.
=== Recommendations on the issue of indoor environment ===
When monitoring changes in homeostasis and their possible correction, we have to keep in mind some general attitudes.
* The decisive factor is the patient's clinical condition. The goal is not "normal" serum [[osmolality]] but good patient status: proper gas exchange, adequate ECKO effectively circulating [[blood]] volume, good [[consciousness]] and [[diuresis|diuresis]], good peripheral circulation. If there is a discrepancy between the clinical findings and the results of laboratory examinations, then we repeat the examination and evaluate the results using the largest possible set of information. The mere fact that the concentration of potassium in the serum is 4.8 mmol/l does not mean anything. To interpret this result, we need at least to know the [[pH]] value, the [[Sodium|Na]] and [[Chloride|Cl]] concentration in the [[serum|serum]], the patient's hydration status, [[kidney| kidney]], [[EKG]] waveform and muscle strength.
* '''Individual parameter''' has a very limited meaning. The trend of changes in homeostasis, monitoring the changes of many parameters over time is important. This is done by balances, waste monitoring of Na, [[Potassium|K]], Cl, [[urea|ureas]] and water, etc. The stability of the internal environment is a dynamic event.
* Changes in homeostasis usually occur ''slowly'', within 48 hours or longer. The organism registers changes, compensates and adapts to them. Trying to correct the deviation from the homeostasis reference range quickly, within minutes, is usually dangerous for the patient. We only correct changes in homeostasis that threaten the patient's vital functions.
* A '''Quick''' correction within seconds to minutes is required by:
::* [[hypoxia]],
::* [[hypotension]],
::* [[hypoglycemia]],
::* [[convulsions]].
All other changes in homeostasis give us the opportunity to comprehensively examine and monitor the patient clinically and with the help of laboratory tests. Judicious correction of possible homeostasis disturbances will be necessary for them so as not to disturb the adaptive and compensatory changes of the organism.




<noinclude>
<noinclude>
== Odkazy ==
== Links ==
=== Související články ===
=== Related Articles ===
* [[Osmolalita séra]]
* [[Serum osmolality]]
* [[Diabetická ketoacidóza]]
* [[Diabetic ketoacidosis]]
=== Reference ===
=== References ===
<references />
<references />
=== Zdroj ===
=== Source ===
* HAVRÁNEK, Jiří: ''Vnitřní prostředí''. (upraveno)
* HAVRÁNEK, Jiří: ''Internal environment''. (edited)


</noinclude>
</noinclude>


[[Kategorie:Patofyziologie]]
[[Category:Pathophysiology]]
[[Kategorie:Patobiochemie]]
[[Category:Pathobiochemistry]]
[[Kategorie:Pediatrie]]
[[Category:Paediatrics]]
[[Kategorie:Vnitřní lékařství]]
[[Category:Internal medicine]]
[[Kategorie:Fyziologie]]
[[Category:Physiology]]

Latest revision as of 22:31, 24 November 2023

The body fluids are the internal environment of the organism. In body fluids, the solvent is water and substances are dissolved in it in ionized or non-ionized form. The ionized form is represented by ``electrolytes, i.e. substances that, when dissolved in water, form positively or negatively charged particles: cations and anions. All metabolic processes take place in body fluids. Maintaining the optimal amount and composition of body fluids is a necessary condition for the functioning of organs, for basic vital functions. We call the stability of the internal environment homeostasis.

Total Body Water[edit | edit source]

While most vital processes take place in ICT, ECT primarily serves as a medium for the transport of substances necessary for these processes. During the development of an individual, not only the total volume of body fluids changes, but also individual compartments, while the concentration of solutes is relatively constant.

Distribution of total body water (CTV)
  • intracellular fluid (ICT),
  • extracellular fluid (ECT),
  • intravascular fluid (IVT = plasma): is bounded by endothelial cells and creates an environment for blood elements,
  • interstitial fluid (IST) and lymph: make up the largest part of ECT, it is inserted between ICT and other parts of ECT, exchange of water and solutes between ICT and ECT takes place in it,
  • transcellular fluid = GIT secretions, urine, CSF, intraocular fluid, sweat in sweat glands etc.,
  • the fluid of fibrous tissue, cartilage and bones: it is actually part of the interstitial fluid, but some solutes such as glucose or larger molecules do not pass freely into this space.

It is true that the younger the child, the greater the proportion of fluids in body weight, and the greater part of body fluids is extracellular, mainly as IST. The younger the child, the smaller the volume of muscles and organs (they contain more ICT) compared to an adult. ECT is also exchanged in an infant during 24 hours 4 times more intensively, with respect to a unit of body weight or body surface, than in an adult organism. Critical conditions in children are always complicated by significant lability of body fluids (rapid onset of dehydration) and relatively high physiological need.

Normal volume of blood in quantity per 1 kg of body weight
  • newborn: 90 ml,
  • 1 to 6 years: 80 ml,
  • 6 to 8 years: 75 ml,
  • adult: 60 to 70 ml.
Representation of major solutes
ICT ECT'
cations
anions

Osmolality[edit | edit source]

The osmolality of body fluids is determined by the amount of particles dissolved in them, which are able to act on the water around them or on the other side of the water-permeable membrane. Particle size does not matter. The amount of particles (solutes) in a unit of solvent mass, expressed per kg or per liter of water, is called "osmolality" and is given in units of mmol/kg, respectively. mOsm/kg. The difference in the amount of osmotically active (water-acting) particles on both sides of the water-permeable membranes is osmotic pressure, the osmotic concentration gradient. We are able to measure and therapeutically influence the osmolality of IVT. Since the main osmotically active component of ECT and blood plasma is sodium, significant deviations in water management are typically manifested in the form of hyponatremia (Na < 130 mmol/l), or hypernatremia (Na > 150 mmol/l). The organism must ensure not only iso-osmolality, but also isoion, not only in the ECT, but also in other compartments.

Effective osmolality (tonicity)[edit | edit source]

Effect of different osmotic pressure on erythrocytes

From a clinical point of view, the so-called effective osmolality (tonicity) is more important, which depends on the number of "non-penetrating" particles in ECT (mainly sodium and anions) and ICT (mainly potassium and phosphate with their anions). It is these solutes that form an osmotic concentration gradient, which develops osmotic activity and thereby affects the distribution of water between ICT and ECT, i.e. it keeps water on its side of the cell membrane.

The values ​​of tonicity and osmolality are mostly identical, but there may be cases when this is not the case: so-called "penetrating" solutes, e.g. temporarily) influence on the osmotic movement of water between individual body compartments. In other words, although azotemia increases total plasma osmolality, it does not affect plasma tonicity. Uncritically accepted values ​​of total osmolality in these patients can therefore lead to an incorrect therapeutic conclusion. Some substances, on the other hand, increase the effective osmolality and are not included in the calculation according to the formula (see formula 2). It can be substances that we use therapeutically (e.g. mannitol) or substances that are found in intoxication (alcohol, methanol). If other exogenous osmotically active substances (e.g. mannitol) are not present in the plasma, osmolality or tonicity can be calculated according to simple formulas:

  • Formula 1: S-osmolality = 2x Na + glycemia + urea
  • Formula 2: Effective osmolality, S-tonicity = 2x (Na + glycemia); 2x Na + 10

[1]

S-tonicity calculates only with "non-penetrating" solutes and represents, from a clinical point of view, the so-called effective osmolality. It only calculates with ions and glucose.

The organism maintains the osmolality of individual compartments within a narrow range, and values ​​of 280 to 295 mmol/kg are considered to be the physiological range of S-osmolality.

Hypoosmolality of plasma S-osmo < 275 mmol/kg indicates a relative excess of body water in relation to body solutes. Hyperosmolality of plasma S-osmo > 295 mmol/kg indicates a relative deficit of body water in relation to body solutes.

Searchtool right.svg For more information see Serum Osmolality.

Idiogenic osmoles[edit | edit source]

When the patient's ECT osmolality suddenly changes, a water shift occurs that immediately balances the differences in osmotic concentration on either side of the cell membrane. Although this rapid compensation reduces the magnitude of the osmotic load in ECT, it is only at the cost of simultaneous drainage and shriveling of the cells (at hyperosmolality of the plasma), or their swelling (with plasma hypoosmolality). The CNS cells also have another compensatory mechanism to prevent osmotic damage, but it is fully manifested only after 6 to 12 hours of plasma hyper/hypoosmolality. With a long-term increase in osmolality, osmotically active particles, so-called ``idiogenic osmoles, are formed by the gradual degradation of cellular macromolecules. Their formation is accompanied by a subsequent rise in intracellular osmolality and an adjustment in the volume of CNS cells. Thanks to this compensation, patients with chronic hypernatremia or diabetic ketoacidosis can tolerate extremely high plasma osmolality values. On the contrary, with a prolonged decrease in osmolality, CNS cells can reduce the number of intracellular solutes and thereby regain their original volume despite the persistent hypoosmolality of the plasma. The existence of this secondary "delayed" compensation must be taken into account in the correction of long-lasting disorders of water homeostasis.

Osmotic window[edit | edit source]

In some clinical situations, it is useful to determine the osmolar/osmotic window (osmolal/osmotic gap, OG), which expresses the difference between the osmolality directly measured by the osmometer and the osmolality calculated according to formula 1.

The physiological value of the osmotic gap is 4 – 12 mmol/kg.

OG is created by measuring solutes that are not included in the formula with an osmometer. If the plasma contains a significant amount of these unaccounted for osmotically active substances (e.g. methanol, ethanol, mannitol, idiogenic osmoles in diabetic ketoacidosis), there will be a large difference between the measured and calculated osmolality values. We will use OG especially in the diagnosis of poisoning. In case of an osmotic window value > 20 mOsm/l with simultaneous MAC of unclear etiology, intoxication with osmotically active substances such as ethanol, methanol, ethylene glycol must be ruled out.

Regulation of body fluid volume[edit | edit source]

The constancy of the volume of body fluids is monitored very carefully. Deviations in the range of plus or minus 1% from the steady state are already registered. Among the various compartments of body fluids, the plasma volume, which is monitored by special volume receptors (voloreceptors), plays a key role in the regulation of CTV. They are on the one hand high pressure baroreceptors in the arterial bed (arcus aortae and sinus caroticus) and low pressure volumoreceptors in the large veins, in the heart and chest. Signals from these receptors are transmitted to regulatory centers in the CNS via the glossopharyngeal nerve, n. vagus and sympathetic. Here in the medulla oblongata, pons Varoli and hypothalamus, stimuli are processed and effector mechanisms such as [[ADH] are activated according to the volume and osmolality of body fluids ], systems renin-angiotensin-aldosterone, kallikrein-bradykinin, renal prostaglandins, natriuretic peptides, [[autonomic nervous system] ] and more. All these mechanisms maintain the balance of body fluid volume (and osmolality) by changes in cardiac activity, vascular lumen, sodium and water excretion. Excretion occurs primarily through the kidneys, skin, exhaled gases and the digestive tract, and is affected by an increase or decrease in thirst and fluid intake.

The primary mechanism of volume regulation of ECT and ICT is renal sodium excretion and increased or decreased fluid intake by the thirst mechanism. Interestingly, volume changes in the body are detected independently of the sodium concentration: through volumoreceptors, but volume regulation is mainly mediated by the regulation of sodium excretion by the kidneys.

Regulation of osmolality of body fluids[edit | edit source]

Stable osmolality of body fluids is maintained by the ability of the kidney to change the osmolality of urine and by influencing water intake through the thirst mechanism. The kidneys are able to change the osmolality of urine in a wide range of 50 to 1400 mmol/kg and thus change the amount of excreted solutes and water as needed.

'Changes in osmolality are monitored by the osmoreceptors of the osmoregulation center in the hypothalamus, which already trigger regulatory mechanisms to adjust osmolality when the osmolality changes by 1%. An increase in serum osmolality is mainly due to an increase in water intake through the thirst mechanism and the secretion of ADH with the formation of concentrated urine. The opposite processes start when osmolality is reduced. The stimulus for ADH secretion is increasing serum osmolality as well as some non-osmolar factors such as hypovolemia, pain, hypoxia, RAAS. ADH secretion is inhibited by S-osmolality < 280 mmol/kg, hypervolemia, left atrial distension. The osmolality at which we feel thirsty (thirst mechanism) is 290 mmol/kg.

Electroneutrality of body fluids[edit | edit source]

Electroneutrality of body fluids together with osmolality are determining factors of body fluid composition. In body fluids, the so-called Gibbson-Donnan equilibrium applies. The electroneutrality of the extracellular fluid can be expressed by the equation (Formula 3):

Na + K + Ca + Mg + H = OH + Cl + HCO3 + CO2 + albumin + phosphates

But precisely to maintain electroneutrality, the concentration of ions in all ECT compartments is not the same. IST has more chlorides than plasma because of the high protein content. In the equation (Formula 3) this is expressed on the anion side by albumin. The negative charge of proteins also contributes to sodium retention in IVT and IST. Starling's Law states that intracapillary hydraulic pressure predominates on the arterial side of the capillary, while at the venous end plasma proteins play a major role in the return of fluid from the IST to the IVT with their [[oncotic pressure|oncotic pressure] ]. Pathological influences, such as hypoalbuminemia or arterial hypertension, can affect water transport.

When it comes to maintaining the electroneutrality between ECT and ICT, active enzymatic mechanisms' such as Na-K-ATPase play a significant role. The electrical forces of non-filterable intracellular anions attract cations from the ECT, primarily sodium. It is actively transported back from the cell. To maintain electroneutrality and osmolality, it is exchanged for potassium that is actively transported intracellularly, where it is the main cation. The maintenance of Na and K concentration gradients is a very energy-demanding process, and factors affecting it can cause serious disturbances in the composition of ECT and ICT.

Too rapid adjustment of hyperosmolality can lead to edema in CNS cells => intracranial hypertension, rapid adjustment of hypoosmolality brings the risk of "shrinking" of CNS cells => pontine myelinolysis syndrome.

Electrolyte homeostasis in neonates[edit | edit source]

Water and electrolyte homeostasis of neonates born at term or preterm differs in many ways from other age categories of children. The water balance of newborns is characterized by very rapid changes in the distribution of water from ECT, but also from ICT, and this mainly happens through the kidneys. Water losses are accompanied by sodium losses, premature infants lose more sodium than term newborns. This can be well documented by examining the excretion fraction for sodium (FE Na), which is usually >5%. Its reduction usually occurs during the 1st month of life, in premature babies this interval is longer. It is a result of renal tubular immaturity. Newborns and premature babies are therefore in a negative sodium balance shortly after birth, which sometimes requires supplementation. Achieving a positive sodium balance is important for further proper growth and development. It is not uncommon for premature infants to manifest late hyponatremia by 4 to 6 weeks of age. This is not a consequence of excessive losses, but is the result of increased incorporation of sodium into tissues during growth acceleration.

The most common causes of hyponatremia in newborns/premature infants:

The most common causes of hypernatremia in newborns/premature infants:

Recommendations on the issue of indoor environment[edit | edit source]

When monitoring changes in homeostasis and their possible correction, we have to keep in mind some general attitudes.

  • The decisive factor is the patient's clinical condition. The goal is not "normal" serum osmolality but good patient status: proper gas exchange, adequate ECKO effectively circulating blood volume, good consciousness and diuresis, good peripheral circulation. If there is a discrepancy between the clinical findings and the results of laboratory examinations, then we repeat the examination and evaluate the results using the largest possible set of information. The mere fact that the concentration of potassium in the serum is 4.8 mmol/l does not mean anything. To interpret this result, we need at least to know the pH value, the Na and Cl concentration in the serum, the patient's hydration status, kidney, EKG waveform and muscle strength.
  • Individual parameter has a very limited meaning. The trend of changes in homeostasis, monitoring the changes of many parameters over time is important. This is done by balances, waste monitoring of Na, K, Cl, ureas and water, etc. The stability of the internal environment is a dynamic event.
  • Changes in homeostasis usually occur slowly, within 48 hours or longer. The organism registers changes, compensates and adapts to them. Trying to correct the deviation from the homeostasis reference range quickly, within minutes, is usually dangerous for the patient. We only correct changes in homeostasis that threaten the patient's vital functions.
  • A Quick correction within seconds to minutes is required by:

All other changes in homeostasis give us the opportunity to comprehensively examine and monitor the patient clinically and with the help of laboratory tests. Judicious correction of possible homeostasis disturbances will be necessary for them so as not to disturb the adaptive and compensatory changes of the organism.


Links[edit | edit source]

Related Articles[edit | edit source]

References[edit | edit source]

  1. ŠAŠINKA, M, et al. Pediatrics. 1 location = Košice edition. Satus, 1998. vol. I and II. ISBN 80-967963-0-5.

Source[edit | edit source]

  • HAVRÁNEK, Jiří: Internal environment. (edited)